Resource Computationally Designed Bispecific Antibodies using Negative State Repertoires Graphical Abstract Highlights

A challenge in the structure-based design of specificity is modeling the negative states, i.e., the complexes that you do not want to form. This is a difficult problem because mutations predicted to destabilize the negative state might be accommodated by small conformational rearrangements. To overcome this challenge, we employ an iterative strategy that cycles between sequence design and protein docking in order to build up an ensemble of alternative negative state conformations for use in specificity prediction. We have applied our technique to the design of heterodimeric CH3 interfaces in the Fc region of antibodies. Combining computationally and rationally designed mutations produced unique designs with heterodimer purities greater than 90%. Asymmetric Fc crystallization was able to resolve the interface mutations; the heterodimer structures confirmed that the interfaces formed as designed. With these CH3 mutations, and those made at the heavy-/light-chain interface, we demonstrate one-step synthesis of four fully IgG-bispecific antibodies.

[1]  Tanja Kortemme,et al.  Assessment of flexible backbone protein design methods for sequence library prediction in the therapeutic antibody Herceptin–HER2 interface , 2011, Protein science : a publication of the Protein Society.

[2]  Costas D Maranas,et al.  Recent advances in computational protein design. , 2011, Current opinion in structural biology.

[3]  Kunihiro Hattori,et al.  Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs. , 2014, Molecular immunology.

[4]  J. Ravetch,et al.  Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.

[5]  Roberto A Chica,et al.  Multistate approaches in computational protein design , 2012, Protein science : a publication of the Protein Society.

[6]  B. Kuhlman,et al.  Computational design of a single amino acid sequence that can switch between two distinct protein folds. , 2006, Journal of the American Chemical Society.

[7]  David Baker,et al.  Computational reprogramming of homing endonuclease specificity at multiple adjacent base pairs , 2010, Nucleic acids research.

[8]  J. Wells,et al.  Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. , 1997, Journal of molecular biology.

[9]  Andrew Leaver-Fay,et al.  A Generic Program for Multistate Protein Design , 2011, PloS one.

[10]  P. Carter,et al.  Alternative molecular formats and therapeutic applications for bispecific antibodies. , 2015, Molecular immunology.

[11]  B. Kuhlman,et al.  A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bonds , 2013, Protein science : a publication of the Protein Society.

[12]  Randall J Lee,et al.  The new face of bispecific antibodies: targeting cancer and much more. , 2006, Experimental hematology.

[13]  Michael J. Gramer,et al.  Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange , 2013, Proceedings of the National Academy of Sciences.

[14]  John Kelly,et al.  Improving biophysical properties of a bispecific antibody scaffold to aid developability , 2013, mAbs.

[15]  L. Presta,et al.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. , 1996, Protein engineering.

[16]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[17]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[18]  David Baker,et al.  Algorithm discovery by protein folding game players , 2011, Proceedings of the National Academy of Sciences.

[19]  Gevorg Grigoryan,et al.  Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway. , 2015, Journal of molecular biology.

[20]  M. Wittekind,et al.  Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects , 2010, The Journal of Biological Chemistry.

[21]  D Huglo,et al.  Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Jihong Wang,et al.  Improving target cell specificity using a novel monovalent bispecific IgG design , 2015, mAbs.

[23]  J. Wolchok,et al.  Monoclonal antibodies in cancer therapy. , 2012, Cancer immunity.

[24]  Roberto A Chica,et al.  Improving the accuracy of protein stability predictions with multistate design using a variety of backbone ensembles , 2014, Proteins.

[25]  Guy Georges,et al.  Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies , 2011, Proceedings of the National Academy of Sciences.

[26]  Leonard G. Presta,et al.  Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc , 2000, The Journal of Immunology.

[27]  J. J. Langone,et al.  Immunochemical techniques. I: Hybridoma technology and monoclonal antibodies , 1986 .

[28]  Wolfgang Schaefer,et al.  Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies , 2012, mAbs.

[29]  J. Ponder,et al.  Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes. , 1987, Journal of molecular biology.

[30]  Alex Nisthal,et al.  Experimental library screening demonstrates the successful application of computational protein design to large structural ensembles , 2010, Proceedings of the National Academy of Sciences.

[31]  Pavel Strop,et al.  Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair. , 2012, Journal of molecular biology.

[32]  Yong-Sung Kim,et al.  A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity , 2013, Molecular Cancer Therapeutics.

[33]  Franklin Peale,et al.  Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site , 2009, Science.

[34]  C. Yanover,et al.  Design of multispecific protein sequences using probabilistic graphical modeling , 2010, Proteins.

[35]  Gevorg Grigoryan,et al.  Design of protein-interaction specificity affords selective bZIP-binding peptides , 2009, Nature.

[36]  Andrew C. Chan,et al.  Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.

[37]  Charles Eigenbrot,et al.  Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction. , 2014, Journal of molecular biology.

[38]  W. Delano,et al.  Convergent solutions to binding at a protein-protein interface. , 2000, Science.

[39]  Andrew R Thomson,et al.  De novo protein design: how do we expand into the universe of possible protein structures? , 2015, Current opinion in structural biology.

[40]  Diego Ellerman,et al.  Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies , 2013, Nature Biotechnology.

[41]  J. Fallas,et al.  Computational design of self-assembling register-specific collagen heterotrimers , 2012, Nature Communications.

[42]  Niles A Pierce,et al.  Protein design is NP-hard. , 2002, Protein engineering.

[43]  D. Ecker,et al.  The therapeutic monoclonal antibody market , 2015, mAbs.

[44]  L. A. Clark,et al.  Influence of canonical structure determining residues on antibody affinity and stability. , 2014, Journal of structural biology.

[45]  G. A. Lazar,et al.  A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens , 2011, mAbs.

[46]  A. Zanghellini,et al.  de novo computational enzyme design. , 2014, Current opinion in biotechnology.

[47]  Andrew Leaver-Fay,et al.  Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface , 2014, Nature Biotechnology.

[48]  Samuel L. DeLuca,et al.  Human Germline Antibody Gene Segments Encode Polyspecific Antibodies , 2013, PLoS Comput. Biol..

[49]  Tanja Kortemme,et al.  Design of Multi-Specificity in Protein Interfaces , 2007, PLoS Comput. Biol..

[50]  Carsten Reinhardt,et al.  Bispecific T-cell engaging antibodies for cancer therapy. , 2009, Cancer research.

[51]  J. Richardson,et al.  De novo design, expression, and characterization of Felix: a four-helix bundle protein of native-like sequence. , 1990, Science.

[52]  J. Huston,et al.  SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies. , 2010, Protein engineering, design & selection : PEDS.

[53]  P. Harbury,et al.  Automated design of specificity in molecular recognition , 2003, Nature Structural Biology.

[54]  Rutilio H. Clark,et al.  A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism* , 2015, The Journal of Biological Chemistry.

[55]  A. C. Cuello,et al.  Hybrid hybridomas and their use in immunohistochemistry , 1983, Nature.

[56]  Tanja Kortemme,et al.  Backbone flexibility in computational protein design. , 2009, Current opinion in biotechnology.